ITHACA — Rheonix, Inc., an Ithaca–based microfluidics company, today announced the addition of Frank Gill as vice president of manufacturing.
Gill will be responsible for formulating and executing the company’s operations strategy as it scales from prototype volumes to fully-automated production of life science and in-vitro diagnostics products, the company said in a news release.
Gill will oversee manufacturing of Rheonix-instrument platforms, reagent kits, and the Rheonix CARD system, an automated-microfluidic platform capable of analyzing raw samples in a variety of applications, the company said.
Most recently, Gill served as director of reagent-manufacturing operations at 454 Life Sciences, a division of the Switzerland–based Roche Group.
Contact Reinhardt at ereinhardt@cnybj.com
OSWEGO, N.Y. — Oswego Health says it had the system’s first robotically assisted surgery using…
JOHNSON CITY, N.Y. — Tioga State Bank (TSB) will open a new branch in Johnson…
UTICA, N.Y. — A report by the Oneida County Childcare Taskforce made a number of…
ITHACA, N.Y. — Cayuga Health System (CHS), based in Ithaca, and Cancer Resource Center of…
DeWITT, N.Y. — MACNY, the Manufacturers Association will use a $6 million federal grant to…
SYRACUSE, N.Y. — The Syracuse Housing Authority (SHA) and the City of Syracuse will use…